These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21455736)

  • 1. Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures.
    Geoffroy V; Paschalis EP; Libouban H; Blouin S; Ostertag A; Chappard D; Cros M; Phipps R; de Vernejoul MC
    Calcif Tissue Int; 2011 Jun; 88(6):464-75. PubMed ID: 21455736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.
    Nam SH; Jeong JH; Che X; Lim KE; Nam H; Park JS; Choi JY
    Bone; 2012 Jan; 50(1):149-55. PubMed ID: 22036912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.
    Allen MR; Turek JJ; Phipps RJ; Burr DB
    Bone; 2011 Jul; 49(1):128-32. PubMed ID: 20637914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W; Balooch G; Balooch M; Jiang Y; Nalla RK; Kinney J; Wronski TJ; Lane NE
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.
    Khedr NF; El-Ashmawy NE; El-Bahrawy HA; Haggag AA; El-Abd EE
    Fundam Clin Pharmacol; 2013 Oct; 27(5):526-34. PubMed ID: 22762129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate.
    Durchschlag E; Paschalis EP; Zoehrer R; Roschger P; Fratzl P; Recker R; Phipps R; Klaushofer K
    J Bone Miner Res; 2006 Oct; 21(10):1581-90. PubMed ID: 16995813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study.
    Boonen S; Orwoll ES; Wenderoth D; Stoner KJ; Eusebio R; Delmas PD
    J Bone Miner Res; 2009 Apr; 24(4):719-25. PubMed ID: 19049326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB; Geusens P; Barton IP; Felsenberg D
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling.
    Kadri A; Funck-Brentano T; Lin H; Ea HK; Hannouche D; Marty C; Lioté F; Geoffroy V; Cohen-Solal ME
    Ann Rheum Dis; 2010 Aug; 69(8):1533-8. PubMed ID: 20525838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
    Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
    J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
    Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
    Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture.
    Geoffroy V; Chappard D; Marty C; Libouban H; Ostertag A; Lalande A; de Vernejoul MC
    Osteoporos Int; 2011 Jan; 22(1):289-97. PubMed ID: 20204596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is cortical bone hip? What determines cortical bone properties?
    Epstein S
    Bone; 2007 Jul; 41(1 Suppl 1):S3-8. PubMed ID: 17466615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.